In this context, GLP-1s and other weightmanagement medications may be most effective when they are: Anchored to clear clinical criteria and outcome-based continuation policies, so that ongoing coverage aligns with demonstrated health improvement and adherence Integrated into broader chronic disease and wellness strategies that emphasize long-term behavioral change, rather than positioned as standalone, short-term solutions By incorporating this emerging evidence into GLP1 benefit design, employers can better balance access, outcomes, and sustainability, supporting employee health while setting realistic expectations about the need for ongoing management to maintain results over time
Also triple agonists have demonstrated to possess anti-neurodegenerative properties, indicating a potential for treating Alzheimers disease by reducing neuroinflammation and oxidative stress, enhancing neuronal health and viability, and minimizing glutamate excitotoxicity (Kopp et al., 2022)
Arch Physiol
Immune Function and Defense Glutathione plays a fundamental role in regulating immune cell function and host defense mechanisms
One of the common side effects of Ozempic is gastrointestinal issues, including constipation
According to a May 2022 update by the World Health Organization, there are currently about 2 billion adults with overweight and 650 million with obesity